FDA import detention food importer bringing in a container of packaged snacks through the Port of Long Beach got a call from her broker on a Wednesday afternoon: FDA had detained the shipment. She assumed, reasonably, that something was wrong with the product. Nothing was. FDA had flagged the entry based on a prior shipment from the same manufacturer eighteen months earlier, one she hadn’t even been involved with. That’s a detail most importers don’t know until it happens to them: FDA doesn’t need to test or even examine the specific goods in front of it to detain a shipment. The agency only needs an appearance of a violation, and prior compliance history with a firm or facility counts.
What Detention Actually Means
FDA detention is not a recall, and it’s not a seizure in the criminal sense. It’s an administrative hold that prevents merchandise from entering U.S. commerce while FDA evaluates whether it complies with the Federal Food, Drug, and Cosmetic Act. The product usually stays in the importer’s physical custody, or the custody of their bonded warehouse or broker, rather than being physically taken by the government. But it can’t move into distribution, can’t be sold, and in most cases can’t even be relocated outside the declared port of entry area without FDA’s knowledge.
When FDA decides a shipment appears to violate the law, the agency issues what’s called a Notice of FDA Action, specifically a Notice of Detention and Hearing, to the importer, the owner, the consignee, and the customs broker of record. That notice does two things at once. It identifies the specific violation FDA is alleging, citing the relevant section of the FD&C Act, and it opens a fixed window during which the importer can respond before the detention becomes a formal refusal.
The Clock Starts the Moment the Notice Issues
This is the part that catches new importers off guard the most. The “respond by” date on a detention notice is typically ten business days out, though FDA can extend that up to twenty calendar days to account for weekends, holidays, and mail transit. That date is not the deadline to complete your response. It’s the deadline to respond to the notice, meaning you need to tell FDA what you’re doing, whether that’s submitting testimony, requesting a hearing, or notifying the agency that a private lab is testing the product, before that date arrives. If your plan requires lab results that won’t come back for three weeks, you say so before the response deadline, and you request an extension with a reasonable basis. Silence past the respond-by date is functionally the same as failing to respond at all, and it moves the shipment toward refusal.
Detention vs. Refusal vs. Exam Hold
Importers frequently use these terms interchangeably, and they shouldn’t, because each stage carries different options and different consequences.
| Stage | What It Means | Importer’s Options | Typical Timeline |
| Exam / sample hold | FDA is reviewing or collecting samples before making a decision | Wait for results; provide requested documentation | Days to a few weeks |
| Detention (Notice of Action) | FDA alleges an appearance of violation | Submit testimony, request reconditioning, request a hearing | Respond within 10 business days (up to 20 calendar days) |
| Refusal (Notice of Action) | FDA has determined the product is inadmissible | Export or destroy within 90 days of refusal | Fixed 90-day window |
Responding to a Detention Notice
Three response paths exist once a Notice of Detention and Hearing arrives, and the right one depends entirely on what’s actually driving the alleged violation. Submitting testimony works when you can show the product doesn’t actually violate the law, private lab results contradicting FDA’s basis for detention, documentation proving proper labeling, or evidence the specific lot in question differs from whatever triggered the flag. Requesting reconditioning applies when the violation is fixable, mislabeled packaging that can be relabeled, or contamination that can be addressed through an approved process, and FDA agrees the correction brings the product into compliance. And requesting an informal hearing lets the owner, consignee, or an authorized representative present testimony directly to FDA about admissibility, which matters most when the underlying facts are disputed rather than the corrective path being obvious.
The response has to go to the FDA office identified on the notice itself, not to CBP and not to a general FDA inbox. That office also handles scheduling the physical examination if one hasn’t already occurred. It’s the importer’s responsibility, not FDA’s, to notify that office once the goods are available for examination, and to keep the product held without distributing it while that review is pending. Distributing product that’s still under an active hold, even by accident through a warehouse mix-up, is one of the fastest ways to convert a detention into a much larger enforcement problem, including a request that CBP demand redelivery of goods that already left the port.
What Triggers the Physical Examination
FDA doesn’t examine every detained shipment physically. Plenty of detentions resolve on paperwork alone, particularly labeling violations where the corrected label and a photograph satisfy the compliance officer. Physical examination and sample collection tend to happen when the alleged violation touches the product itself rather than its documentation: suspected adulteration such as pesticide residue, heavy metal contamination, or microbial issues in food products, questions about whether a cosmetic ingredient matches its declared formulation, or radiation-emitting electronics that require Form FDA 2877 certification and haven’t provided it. In those cases, the compliance officer listed on the notice coordinates sample pull logistics, and the importer typically has the option to have an independent lab run parallel testing, provided FDA is notified of that plan before the response deadline rather than after results come back.
Reconditioning: The Middle Path
Reconditioning gets underused because importers assume detention means the shipment is a loss. It often isn’t. If a product’s violation stems from something correctable, like a labeling defect, missing declaration, or a certification form that simply wasn’t filed with the entry, FDA can approve a plan to bring the goods into compliance without requiring export or destruction. The importer proposes the specific correction, and depending on what it involves, FDA may require an investigator to visually confirm the work, particularly for relabeling. This path takes coordination and it takes time, but it’s frequently faster and cheaper than exporting a full container and re-importing corrected product from scratch.
If the Shipment Gets Refused
Once FDA issues a Notice of FDA Action – Refusal, the options narrow sharply. The importer has 90 days from the date of refusal to export or destroy the goods under CBP and FDA supervision. Overcoming a refusal after it’s issued is possible but difficult, and it requires evidence compelling enough to show FDA made an actual error in the refusal determination, not just a renewed version of the argument that didn’t succeed at the detention stage. This is why the response during the detention window matters so much more than most importers initially treat it: it’s the point where you have the most room to argue, before the determination hardens into a refusal that’s genuinely hard to unwind.
When USDA Jurisdiction Overlaps With FDA’s
Food importers in particular run into a jurisdictional split that isn’t obvious from the outside. FDA regulates most packaged food, but USDA’s Food Safety and Inspection Service holds jurisdiction over meat, poultry, and certain egg products, and a detention notice from one agency doesn’t mean the other agency’s requirements are satisfied. We’ve had clients resolve an FDA labeling detention only to discover a separate USDA hold on the same container because a component ingredient crossed into USDA’s jurisdiction. Knowing which agency actually governs your specific product, and confirming that before the goods ever ship, avoids finding out the hard way that you satisfied one agency’s notice while a second one was still sitting open on the same entry.
Where a Broker’s Role Fits Into the Response
A detention notice arrives on the customs broker’s desk at the same time it arrives on the importer’s, and the broker’s job during that window goes beyond simply relaying the notice. A broker who understands the client’s product line can usually tell within a day whether the alleged violation is a documentation gap that reconditioning will fix, or a substantive issue that needs lab testing and a longer response. That triage matters because it determines whether you’re looking at a shipment released in a week or one that sits for a month. It’s also worth knowing that the entry itself, separate from the detention, is still subject to the same customs brokerage compliance obligations as any other import, including proper customs bond coverage sufficient to cover potential liquidated damages if the detention drags into a redelivery demand.
If the detained shipment later ends up re-exported rather than sold domestically, that export can sometimes create a duty drawback opportunity on duties already paid at entry, which is a detail worth raising with your broker rather than assuming a refused shipment is a pure loss with no recovery angle at all. And if the underlying dispute involves a classification or valuation disagreement layered on top of the FDA issue, that’s a separate track that may eventually involve a protest or PSC filing with CBP, independent of whatever FDA ultimately decides about admissibility.
Frequently Asked Questions
How long do I have to respond to an FDA detention notice? Typically ten business days, though FDA can extend that up to twenty calendar days to account for weekends, holidays, and mailing time. The date is the deadline to respond, not necessarily the deadline to complete every step of your response, such as lab testing.
Can I request more time to respond to a detention notice? Yes, provided the request is made within the original response window and includes a reasonable basis for the extension. If granted, FDA issues a new Notice of FDA Action reflecting the updated timeframe.
Who is allowed to respond to a Notice of Detention and Hearing? The owner or consignee, or an authorized representative acting on their behalf with written authorization. The importer of record, who may be the broker, consignee, or bond owner, is also recognized as eligible to provide information.
Can my detained product be moved to a different warehouse while I wait for a decision? There’s no absolute prohibition, but FDA expects the entry process to be conducted within the declared port of entry area, and moving product without notifying FDA risks complicating the examination and response process.
What happens if I don’t respond to the detention notice at all? FDA’s compliance officer can issue a refusal of admission if no response arrives by the respond-by date. Once refused, the product must be exported or destroyed within 90 days, and reversing that outcome is significantly harder than responding on time in the first place.
Does FDA have to test my specific product before detaining it? No. FDA can detain based on the appearance of a violation alone, including based on prior findings from an earlier shipment tied to the same manufacturer or facility, without testing or physically examining the specific goods currently detained.
Can a detained shipment ever be released without reconditioning, testing, or export? Yes, if the importer’s submitted testimony and documentation are sufficient on their own to overcome the appearance of a violation, without requiring physical correction or laboratory confirmation.
If a shipment lands in FDA detention, the ten-business-day clock is already running before most importers even open the notice. Book a free consultation and we’ll help you build the response before that window closes.